BCR–ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.